Clinical Trial: A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia

U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT06903702) titled 'A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia' on March 25.

Brief Summary: The researchers are doing this study to find out if an allogeneic hematopoietic stem cell transplant (HSCT) or maintenance therapy with azacitidine and venetoclax is more effective at keeping AML from coming back (relapsing).

Study Start Date: March 31

Study Type: INTERVENTIONAL

Condition: Acute Myeloid Leukemia

Intervention: DRUG: Azacitidine (AZA)

given daily for 7 days starting on Day 1 of each Cycle

DRUG: Venetoclax

orally daily for 28 days

PROCEDURE: Allogeneic hemat...